Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis

Completed · Phase 2

Conditions studied: Bacterial Conjunctivitis

In brief

The purpose of this study is to evaluate the microbiological and clinical efficacy of Auriclosene compared to its vehicle for bacterial conjunctivitis. Adults and children one year of age and older with bacterial conjunctivitis in at least one eye may be eligible. Subjects will be randomly assigned to receive either Auriclosene Ophthalmic Solution or Vehicle Ophthalmic Solution.

Key facts

Study ID

NCT01877694

Run by

NovaBay Pharmaceuticals, Inc.

People needed

217

Starts

2013-06-01

Expected to finish

2015-01-01

Last updated by the study team

2015-05-28

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 1 year of age and older
• Bulbar conjunctival injection
• Conjunctival discharge/exudate
• Signs and symptoms of bacterial conjunctivitis in at least one eye for 3 days or less
• Other inclusion criteria per protocol

You may not qualify if…

• Suspected fungal, viral, Chlamydia or Acanthamoeba co-infection based on clinical diagnosis
• Any drug treatment in either eye for the current episode of bacterial conjunctivitis prior to study enrollment
• Other exclusion criteria per protocol

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Phoenix, Arizona, United States
• Study site — Anaheim, California, United States
• Study site — Bellflower, California, United States
• Study site — Glendale, California, United States
• Study site — Huntington Beach, California, United States
• Study site — Clearwater, Florida, United States
• Study site — Woodstock, Georgia, United States
• Study site — Evansville, Indiana, United States
• Study site — Newton, Kansas, United States
• Study site — Whitehouse Station, New Jersey, United States
• Study site — Huntersville, North Carolina, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Dayton, Ohio, United States
• Study site — Corsicana, Texas, United States
• Study site — San Antonio, Texas, United States
• Study site — Clinton, Utah, United States
• Study site — Charlottesville, Virginia, United States
• Study site — Midlothian, Virginia, United States
• Study site — Spokane, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.